Glenmark Life Sciences Limited
Glenmark Life Sciences Limited (GLS.NS) Stock Overview
Explore Glenmark Life Sciences Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
133.1B
P/E Ratio
57.28
EPS (TTM)
$34.48
ROE
0.09%
GLS.NS Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Glenmark Life Sciences Limited (GLS.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1252.15.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 57.28 and a market capitalization of 133.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.